ChromaDex (CDXC)
(Delayed Data from NSDQ)
$3.38 USD
-0.09 (-2.59%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $3.38 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
D Value A Growth A Momentum B VGM
Income Statements
Fiscal Year end for ChromaDex Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 84 | 72 | 67 | 59 | 46 |
Cost Of Goods | 33 | 29 | 26 | 24 | 21 |
Gross Profit | 51 | 43 | 41 | 35 | 26 |
Selling & Adminstrative & Depr. & Amort Expenses | 56 | 61 | 69 | 55 | 57 |
Income After Depreciation & Amortization | -6 | -19 | -27 | -20 | -31 |
Non-Operating Income | 1 | 2 | 0 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 1 |
Pretax Income | -5 | -17 | -27 | -20 | -32 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -5 | -17 | -27 | -20 | -32 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -5 | -17 | -27 | -20 | -32 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -5 | -18 | -26 | -19 | -29 |
Depreciation & Amortization (Cash Flow) | 1 | 1 | 1 | 1 | 2 |
Income After Depreciation & Amortization | -6 | -19 | -27 | -20 | -31 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 74.99 | 69.73 | 67.19 | 61.07 | 57.06 |
Diluted EPS Before Non-Recurring Items | -0.07 | -0.27 | -0.40 | -0.33 | -0.52 |
Diluted Net EPS (GAAP) | -0.07 | -0.24 | -0.40 | -0.33 | -0.56 |
Fiscal Year end for ChromaDex Corporation falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | 22.74 | 22.15 | 21.20 | 19.50 | 20.32 |
Cost Of Goods | 9.05 | 8.70 | 8.26 | 7.53 | 7.97 |
Gross Profit | 13.69 | 13.46 | 12.94 | 11.97 | 12.36 |
SG&A, R&D, and Dept/Amort Expenses | 13.95 | 14.19 | 13.11 | 13.12 | 14.68 |
Income After SG&A, R&D, and Dept/Amort Expenses | -0.26 | -0.73 | -0.17 | -1.15 | -2.32 |
Non-Operating Income | 0.24 | 0.24 | 0.28 | 0.19 | 0.13 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -0.01 | -0.49 | 0.11 | -0.96 | -2.19 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -0.02 | -0.49 | 0.11 | -0.96 | -2.19 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -0.02 | -0.49 | 0.11 | -0.96 | -2.19 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | 75.56 | 75.23 | 75.12 | 75.05 | 74.97 |
Diluted EPS Before Non-Recurring Items | 0.00 | -0.01 | 0.00 | -0.01 | -0.03 |
Diluted Net EPS (GAAP) | 0.00 | -0.01 | 0.00 | -0.01 | -0.03 |